GLOMERULAR EPITHELIAL CELL METABOLISM IN DIABETES MELLIT
糖尿病的肾小球上皮细胞代谢
基本信息
- 批准号:3242299
- 负责人:
- 金额:$ 12.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-04-01 至 1995-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Diabetic nephropathy is characterized by significant derangements in the
biochemical constituents of the glomerular basement membrane eg. heparan
sulfate proteoglycan, sialic acid. Although these abnormalities are
implicated in the pathogenesis of proteinuria, the underlying mechanisms
are not known. Studies on pathogenesis of diabetic complications
affecting other tissues eg. lens, peripheral nerves, have suggested an
important role for alcohol derivatives of glucose i.e. sorbitol, myo-
inositol (polyols). Agents that correct the abnormalities in polyol
metabolism in these tissues have been shown to reverse their functional
disturbances. We have successfully grown pure populations of cloned
glomerular epithelial cells which express in vitro the characteristics of
these cells in vivo eg. expression of heparan sulfate, sialic acid,
collagen. We propose to test the hypothesis that abnormalities in the
glomerular epithelial cell polyol metabolism are responsible for the
derangements in glomerular HSPG metabolism and sialic acid content seen in
diabetic glomerulopathy. Our specific aims are:
I. To determine the effect of altered medium concentrations of glucose
and insulin on the rates of synthesis and catabolism of core protein and
glycosaminoglycan moieties of heparan sulfate proteoglycan.
II. Evaluation of mechanisms involved: To assess whether correcting
insulin lack, preventing or reversing abnormalities in sorbitol and
myoinositol rectify changes found in the synthesis and catabolism of
heparan sulfate proteoglycan.
III. (a) To study the effects of altered medium concentrations of glucose
and insulin on the sialic acid content of the glomerular epithelia cells
and on the overall cell surface electrical charge of the cells. (b) To
investigate whether correcting (i) insulin lack (ii) abnormalities in
sorbitol and myo-inositol rectify changes in sialic acid content and
abnormalities in surface electrical charge.
These studies will advance our understanding of the mechanisms underlying
the abnormalities in the metabolism of biochemical determinants of
glomerular permselectivity. This knowledge may pave way to design
therapeutic strategies for diabetic nephropathy that causes enormous
morbidity and mortality.
糖尿病肾病的特征是在肾脏中的
肾小球基底膜的生化成分,如乙酰肝素
硫酸化蛋白聚糖、唾液酸。 虽然这些异常是
与蛋白尿的发病机制有关,
不知道。 糖尿病并发症的发病机制研究
影响其他组织,透镜,周围神经,都表明
葡萄糖的醇衍生物,即山梨糖醇,肌
肌醇(多元醇)。 纠正多元醇异常的试剂
这些组织中的代谢已经显示出逆转它们的功能
干扰. 我们已经成功地培育出了
肾小球上皮细胞,在体外表达的特点,
这些细胞在体内例如硫酸乙酰肝素,唾液酸,
胶原 我们建议测试的假设,在异常的
肾小球上皮细胞多元醇代谢负责
肾小球HSPG代谢和唾液酸含量的紊乱,
糖尿病性肾小球病 我们的具体目标是:
I. 为了确定改变培养基中葡萄糖浓度的影响,
和胰岛素对核心蛋白的合成和催化速率的影响,
硫酸乙酰肝素蛋白聚糖的糖胺聚糖部分。
二. 评估所涉及的机制:评估是否纠正
胰岛素缺乏,预防或逆转山梨醇异常,
肌醇纠正在合成和催化中发现的变化,
硫酸乙酰肝素蛋白聚糖。
三. (a)研究改变培养基中葡萄糖浓度的影响
胰岛素对肾小球上皮细胞唾液酸含量的影响
以及电池的整个电池表面电荷。 (b)到
研究是否纠正(i)胰岛素缺乏(ii)
山梨醇和肌醇纠正唾液酸含量的变化,
表面电荷异常。
这些研究将促进我们对潜在机制的理解
在代谢的生化决定因素的异常,
肾小球选择透过性 这些知识可以为设计
糖尿病肾病的治疗策略,
发病率和死亡率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BALAKUNTALAM S KASINATH其他文献
BALAKUNTALAM S KASINATH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BALAKUNTALAM S KASINATH', 18)}}的其他基金
GLOMERULAR EPITHELIAL CELL METABOLISM IN DIABETES
糖尿病中的肾小球上皮细胞代谢
- 批准号:
3242296 - 财政年份:1990
- 资助金额:
$ 12.85万 - 项目类别:
相似海外基金
Complete inhibition of ROCK signaling in diabetic nephropathy
完全抑制糖尿病肾病中的 ROCK 信号传导
- 批准号:
23K07709 - 财政年份:2023
- 资助金额:
$ 12.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a novel therapeutic approach for diabetic nephropathy by nucleic acid medicine (DNA aptamer).
开发核酸药物(DNA 适体)治疗糖尿病肾病的新方法。
- 批准号:
23K07732 - 财政年份:2023
- 资助金额:
$ 12.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Single Cell Landscape of Early Human Diabetic Nephropathy
早期人类糖尿病肾病的单细胞景观
- 批准号:
10765844 - 财政年份:2023
- 资助金额:
$ 12.85万 - 项目类别:
The analysis of the pathophysiology of MR activation-mediated diabetic nephropathy and the exploration of its novel therapeutic approaches.
MR激活介导的糖尿病肾病的病理生理学分析及其新治疗方法的探索。
- 批准号:
22K20914 - 财政年份:2022
- 资助金额:
$ 12.85万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Dual Oxidase 2 as a New Target for Treatment of Diabetic Nephropathy
双氧化酶2作为糖尿病肾病治疗新靶点
- 批准号:
10624760 - 财政年份:2022
- 资助金额:
$ 12.85万 - 项目类别:
The gut-renal axis in diabetic nephropathy mediated by segmented filamentous bacteria
分节丝状菌介导的糖尿病肾病肠肾轴
- 批准号:
22K17768 - 财政年份:2022
- 资助金额:
$ 12.85万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Dual Oxidase 2 as a New Target for Treatment of Diabetic Nephropathy
双氧化酶2作为糖尿病肾病治疗新靶点
- 批准号:
10334036 - 财政年份:2022
- 资助金额:
$ 12.85万 - 项目类别:
The Single Cell Landscape of Early Human Diabetic Nephropathy
早期人类糖尿病肾病的单细胞景观
- 批准号:
10368354 - 财政年份:2022
- 资助金额:
$ 12.85万 - 项目类别:
Development of a scoring system for predicting diabetic nephropathy severity using urinary podocyte markers.
开发使用尿足细胞标记物预测糖尿病肾病严重程度的评分系统。
- 批准号:
22K07448 - 财政年份:2022
- 资助金额:
$ 12.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cytosine methylation predicts diabetic nephropathy progression
胞嘧啶甲基化预测糖尿病肾病进展
- 批准号:
nhmrc : 2003401 - 财政年份:2021
- 资助金额:
$ 12.85万 - 项目类别:
Ideas Grants














{{item.name}}会员




